The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis.
about
Iontophoresis of lidocaine for anesthesia during pulsed dye laser treatment of port-wine stains.Iontophoresis: a potential emergence of a transdermal drug delivery system.Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain.Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis.Microdialysis and delivery of iontophoresis-driven lidocaine into the human gastrocnemius muscle.Absorption of iontophoresis-driven 2% lidocaine with epinephrine in the tissues at 5 mm below the surface of the skin.Temporomandibular disorders. Part 2: conservative management.Assessment of phonophoresis and iontophoresis in the treatment of carpal tunnel syndrome: a randomized controlled trial.Treatment of plantar fasciitis by iontophoresis of 0.4% dexamethasone. A randomized, double-blind, placebo-controlled study.In vitro optimization of dexamethasone phosphate delivery by iontophoresis.Iontophoretic delivery of nitric oxide donor improves local skin flap viability.Gold nanoparticles and diclofenac diethylammonium administered by iontophoresis reduce inflammatory cytokines expression in Achilles tendinitis.Iontophoresis with cortisone in the treatment of lateral epicondylalgia (tennis elbow)--a double-blind study.Iontophoretic administration of dexamethasone sodium phosphate for acute epicondylitis. A randomized, double-blinded, placebo-controlled study.Iontophoretic drug delivery using the IOMED Phoresor system.Effect of perfusion flow rate on the tissue uptake of solutes after dermal application using the rat isolated perfused hindlimb preparation.
P2860
Q33209912-C99DE63F-F10D-40D4-AEE8-67BB462DFC1EQ34259364-C552A7F6-68A6-40D1-B131-93E8891A8DB8Q34573250-2E562ACE-D55F-43B3-BDCF-822793FB2B7FQ35476683-50D5DDB5-0FEE-473C-8546-B454F0E49D34Q36165574-1D3E6C34-D4AF-449E-B7D5-084E27828752Q36165579-8C30334C-C034-49BC-B47C-28F0E24876F1Q38224457-C251F191-E2C8-419B-99B6-465C0BAD174AQ39275368-CCE356E9-2D02-4CC4-BE0C-7CFE0F1A2DBFQ39456033-6D506DB4-7214-46CA-832B-C575BA6730D0Q41820350-8820834E-686A-40E3-84F6-AB2E0C63CF8FQ41878749-C57F7161-73C0-4CB9-8151-3EECADBB1353Q42175138-A0F7A714-CB8F-46EF-BBBC-53C8FD5F6480Q44075178-5A715A28-95D5-4C7F-AFA2-EAD64499524FQ44892782-5ACD4764-E03E-4910-951A-98681896D050Q48754903-F5238492-A48A-48DC-BAF0-1DA18481F5EAQ51624878-EE17EAB5-E0EC-4958-A163-30C0CB81776C
P2860
The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
The quantity and distribution ...... ed to tissue by iontophoresis.
@en
The quantity and distribution ...... ed to tissue by iontophoresis.
@nl
type
label
The quantity and distribution ...... ed to tissue by iontophoresis.
@en
The quantity and distribution ...... ed to tissue by iontophoresis.
@nl
prefLabel
The quantity and distribution ...... ed to tissue by iontophoresis.
@en
The quantity and distribution ...... ed to tissue by iontophoresis.
@nl
P2093
P1476
The quantity and distribution ...... ed to tissue by iontophoresis.
@en
P2093
P304
P356
10.1111/J.1365-4362.1980.TB00380.X
P577
1980-11-01T00:00:00Z